Eradicatus Infectus Private Limited

Eradicatus Infectus Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U73100DL2019PTC358370 Incorporated 04 December 2019 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹9.15 Cr
▲ 1304.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹9.8 Lakh
Satisfied ₹95.86 Lakh
Company age
7 yrs
Est. 2019
Employees · EPFO
8
Latest available

About Eradicatus Infectus Private Limited

Data last updated: 18 December 2025

Eradicatus Infectus Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 04 December 2019, the company has been in operation for over 7 years.

Registered with ROC Delhi under CIN U73100DL2019PTC358370.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Preeti Tank and Anubhav Anusha.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: D – 34 3Rd Floor, Anand Niketan, New Delhi, Delhi, India – 110021.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.15 Cr, reflecting significant growth compared to the previous year.

The company has a workforce of approximately 8 employees as per the latest available data. Its group structure includes 2 subsidiaries.

As per MCA filings, the company has open charges of ₹9.8 Lakh and satisfied charges of ₹95.86 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genestore.org.

Company Details of Eradicatus Infectus Private Limited
CIN U73100DL2019PTC358370
Registration Number 358370
Incorporation Date 04 December 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    D – 34 3Rd Floor, Anand Niketan, New Delhi, Delhi, India – 110021
  • Industry
    Pharma, Pharma Contract R&D
Company report
Eradicatus Infectus Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Eradicatus Infectus Private Limited report

Financials, compliance, directors, charges, ownership and filings for Eradicatus Infectus Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Eradicatus Infectus Private Limited

Eradicatus Infectus Private Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q6 Other Hospital and Medical Care Activities Locked
Premium access

Business activity turnover details for Eradicatus Infectus Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Eradicatus Infectus Private Limited

Eradicatus Infectus Private Limited is audited by O.P. Bagla & Co. LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
O.P. Bagla & Co. LLP Locked Locked Locked
Premium access

Complete auditor history for Eradicatus Infectus Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Eradicatus Infectus Private Limited

Eradicatus Infectus Private Limited is currently managed by 2 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Preeti Tank Director 04 Dec 2019 6 Years 8 Months Current
Anubhav Anusha Director 18 Jul 2025 1 Years 0 Months Current

Financials of Eradicatus Infectus Private Limited FY 2024 filings available

Eradicatus Infectus Private Limited reported revenue of ₹9.15 Cr (up 1304.00% YoY) for FY 2025.

Revenue · FY 2025
₹9.15 Cr ▲ 1304.00%
Premium access

Ten-year financial statements for Eradicatus Infectus Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Eradicatus Infectus Private Limited

Premium access

Shareholding and ownership data for Eradicatus Infectus Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Eradicatus Infectus Private Limited

Eradicatus Infectus Private Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Eradicatus Infectus Private Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Franco Alliance Private Limited U85100DL2021PTC378228 Locked
Pathstore Dx Rx India Private Limited U85300DL2022PTC396079 Locked

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Eradicatus Infectus Private Limited

Open charges
₹9.8 Lakh
Satisfied charges
₹95.86 Lakh
Breakdown by lending institutions
Others₹0.10 Cr
Latest charge details
DateLenderAmountStatus
22 Dec 2023 Others ₹9.8 Lakh Open
26 Aug 2022 Axis Bank Limited ₹95.86 Lakh Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Eradicatus Infectus Private Limited

Eradicatus Infectus Private Limited has a workforce of 8 employees as of Mar 25, 2025.

Employee count
8
Active EPFO establishments
1
Employee growth
-33.33%
Premium access

Employee and EPFO history for Eradicatus Infectus Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Eradicatus Infectus Private Limited

Premium access

GST registrations and filing compliance for Eradicatus Infectus Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Eradicatus Infectus Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Eradicatus Infectus Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Eradicatus Infectus Private Limited

Premium access

MSME payment history for Eradicatus Infectus Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Eradicatus Infectus Private Limited

Premium access

Corporate group structure for Eradicatus Infectus Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Eradicatus Infectus Private Limited

Premium access

MCA filings and documents for Eradicatus Infectus Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Eradicatus Infectus Private Limited

Directors
18 Jul 2025
Anubhav Anusha was appointed as a Director on 18 Jul 2025 & has been associated with this company since 1 year 29 days.
Activity
30 Sep 2024
Eradicatus Infectus Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Eradicatus Infectus Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
15 Jan 2024
A charge registered on 26 Aug 2022 via Charge ID 100606183 with Axis Bank Limited was fully satisfied on 15 Jan 2024.
Charges
22 Dec 2023
A charge with Others amounted to Rs. 9.80 Lakh with Charge ID 100849026 was registered on 22 Dec 2023.
Charges
26 Aug 2022
A charge with Axis Bank Limited amounted to Rs. 95.86 Lakh with Charge ID 100606183 was registered on 26 Aug 2022.

Frequently Asked Questions about Eradicatus Infectus Private Limited

Eradicatus Infectus Private Limited is an active private limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 04 December 2019 (7+ years old) and is registered under CIN U73100DL2019PTC358370. The company has 8 employees.

Eradicatus Infectus Private Limited reported revenue of ₹9.15 Cr for FY 2025 (up 1304.00% YoY).

The current directors of Eradicatus Infectus Private Limited are:

The primary industry of Eradicatus Infectus Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Yes, Eradicatus Infectus Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Eradicatus Infectus Private Limited can be reached at the registered office: D – 34 3Rd Floor, Anand Niketan, New Delhi, Delhi, India – 110021, or through the website genestore.org.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available